Skip to main content
. 2020 Dec 10;11:600561. doi: 10.3389/fphar.2020.600561

FIGURE 3.

FIGURE 3

Differentially expressed proteins pathway enrichment analysis. (A) The most significantly (p < 0.05) enriched GO terms (Top 20) in rat treated with doxorubicin. (B) The most significantly (p < 0.05) enriched KEGG pathways (Top 20) in rat treated with doxorubicin. (BP: biological process; MF: molecular function; CC: cellular component).